Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2.
Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2.
复制标题
DOI:
10.1038/s41392-020-00350-0
复制
发表时间:
2020-10-09
影响因子:
39.3
通讯作者:
Kutateladze TG
中科院分区:
文献类型:
--
作者:
Vann KR;Tencer AH;Kutateladze TG
Structural analysis of SARS-CoV-2 virulence factors is crucial for the development of vaccines and anti-viral therapeutics. Recent cryo-EM structures of the viral protein Nsp1 bound to the human ribosomal machinery shed light onto the mechanism of translational shutdown and blockage of host immune response. 1 The global pandemic of COVID-19 has been ravaging the world for several months and continues posing an enormous threat to public health. This outbreak is the most serious pandemic occurred in the last 2 decades with morbidity reaching 18 million as of August 2020. The causative agent of COVID-19—Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2)—belongs to the group of highly pathogenic beta-coronaviruses that also includes SARS-CoV and MERS-CoV, which caused respiratory diseases in 2002 and 2012. The SARS-CoV-2 and SARS-CoV viruses are closely related and share~ 80% nucleotide identity in their single-stranded RNA genomes. The SARS-CoV-2 genome encodes four structural proteins, such as Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N), several non-structural proteins (Nsp), and the open-reading frame (ORF1a and ORF1ab) precursor polyproteins that are proteolytically cleaved in the host cells producing an additional set of Nsps, including Nsp1 (Fig. 1 a). Nsp1 of SARS-CoV has been shown to act as a major virulence factor. It binds to the small ribosomal subunit, inhibiting production of host proteins by blocking messenger RNA (mRNA) translation and promoting degradation of host mRNA. Importantly, by inducing a near complete shutdown of translation of host proteins, including interferons, Nsp1 destroys the defense mechanisms of the innate immune system and facilitates viral replication. Owning to its crucial role in immune response dysregulation, Nsp1 of SARS-CoV-2 may represent an attractive pharmacological target in the fight against COVID-19.Recent structural studies of Nsp1 of SARS-CoV-2 by Thoms et al. 1 and Schubert et al. 2 illuminated the molecular mechanism by which Nsp1 binds to the human ribosomal machinery and can be instrumental in guiding the development of inhibitors and vaccines. Thoms et al. 1 report that Nsp1 strongly associates with purified human ribosomal 40S subunit and 80S ribosomes, but not with actively translating polyribosomes and that the presence of Nsp1 precludes mRNA translation in vitro and in HEK293T cells. The authors also found that the C-terminal residues K164 and H165 of Nsp1, comprising the KH motif, which is conserved in SARS-CoV, are required for this interaction and inhibition of translation. Mutation of the KH motif reduces the ability of Nsp1 to associate with ribosomal subunits and block host mRNA translation.
影响因子:
64.8
作者:
Gordon, David E.;Jang, Gwendolyn M.;Krogan, Nevan J.
通讯作者:
Krogan, Nevan J.
影响因子:
56.9
作者:
Thoms, Matthias;Buschauer, Robert;Beckmann, Roland
通讯作者:
Beckmann, Roland
影响因子:
56.9
作者:
Gao, Yan;Yan, Liming;Rao, Zihe
通讯作者:
Rao, Zihe